Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tevogen Bio Holdings Inc. - Warrant
(NQ:
TVGNW
)
0.0358
-0.0011 (-2.98%)
Streaming Delayed Price
Updated: 2:09 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tevogen Bio Holdings Inc. - Warrant
< Previous
1
2
3
4
5
6
Next >
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
July 18, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
July 17, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
July 16, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
July 14, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
July 10, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
June 30, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
June 18, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
June 09, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
May 30, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
May 27, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 27, 2025
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting
May 22, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
May 23, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Gapping stocks in Monday's session
↗
May 19, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Top stock movements in today's session.
↗
May 16, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
The market is filled with gapping stocks in Friday's session.
↗
May 16, 2025
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via
Chartmill
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
May 12, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
May 02, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
April 30, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
April 29, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
April 29, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
April 28, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Announces 2025 Annual Meeting
April 25, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
April 17, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
April 15, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
April 14, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
April 09, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
April 08, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
April 07, 2025
From
Tevogen Bio Inc
Via
GlobeNewswire
Friday's pre-market session: top gainers and losers
↗
April 04, 2025
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
